Protective and Detrimental Roles of p38α Mitogen‐Activated Protein Kinase in Different Stages of Nonalcoholic Fatty Liver Disease
Authors:
- 1 September 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 72 (3) , 873-891
Abstract
Background and Aims: Neutrophil infiltration is a hallmark of nonalcoholic steatohepatitis (NASH), but how this occurs during the progression from steatosis to NASH remains obscure. Human NASH features hepatic neutrophil infiltration and up‐regulation of major neutrophil‐recruiting chemokines (e.g., chemokine [C‐X‐C motif] ligand 1 [CXCL1] and interleukin [IL]‐8). However, mice fed a high‐fat diet (HFD) only develop fatty liver without significant neutrophil infiltration or elevation of chemokines. The aim of this study was to determine why mice are resistant to NASH development and the involvement of p38 mitogen‐activated protein kinase (p38) activated by neutrophil‐derived oxidative stress in the pathogenesis of NASH. Approach and Results: Inflamed human hepatocytes attracted neutrophils more effectively than inflamed mouse hepatocytes because of the greater induction of CXCL1 and IL‐8 in human hepatocytes. Hepatic overexpression of Cxcl1 and/or IL‐8 promoted steatosis‐to‐NASH progression in HFD‐fed mice by inducing liver inflammation, injury, and p38 activation. Pharmacological inhibition of p38α/β or hepatocyte‐specific deletion of p38a (a predominant form in the liver) attenuated liver injury and fibrosis in the HFD +Cxcl1 ‐induced NASH model that is associated with strong hepatic p38α activation. In contrast, hepatocyte‐specific deletion of p38a in HFD‐induced fatty liver where p38α activation is relatively weak exacerbated steatosis and liver injury. Mechanistically, weak p38α activation in fatty liver up‐regulated the genes involved in fatty acid β‐oxidation through peroxisome proliferator‐activated receptor alpha phosphorylation, thereby reducing steatosis. Conversely, strong p38α activation in NASH promoted caspase‐3 cleavage, CCAAT‐enhancer‐binding proteins homologous protein expression, and B cell lymphoma 2 phosphorylation, thereby exacerbating hepatocyte death. Conclusions: Genetic ablation of hepatic p38a increases simple steatosis but ameliorates oxidative stress‐driven NASH, indicating that p38α plays distinct roles depending on the disease stages, which may set the stage for investigating p38α as a therapeutic target for the treatment of NASH.Keywords
Funding Information
- National Institute on Alcohol Abuse and Alcoholism (The intramural program)
This publication has 42 references indexed in Scilit:
- The complexity of NF-κB signaling in inflammation and cancerMolecular Cancer, 2013
- Discovery of PH-797804, a highly selective and potent inhibitor of p38 MAP kinaseBioorganic & Medicinal Chemistry Letters, 2011
- Hepatic Expression Patterns of Inflammatory and Immune Response Genes Associated with Obesity and NASH in Morbidly Obese PatientsPLOS ONE, 2010
- Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytesHepatology, 2007
- Modulation of PPAR activity via phosphorylationBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2007
- Interfering with MAP Kinase Docking Interactions: Implications and Perspectives for the p38 RouteCell Cycle, 2007
- Bcl-2 Phosphorylation by p38 MAPKJournal of Biological Chemistry, 2006
- Activation and signaling of the p38 MAP kinase pathwayCell Research, 2005
- Roles of CHOP/GADD153 in endoplasmic reticulum stressCell Death & Differentiation, 2003
- p38 Mitogen-activated Protein Kinase Activates Peroxisome Proliferator-activated Receptor αJournal of Biological Chemistry, 2001